{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:43:23Z","timestamp":1791297803488,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1053\/j.seminoncol.2012.11.011","type":"journal-article","created":{"date-parts":[[2013,2,5]],"date-time":"2013-02-05T01:18:46Z","timestamp":1360027126000},"page":"100-108","source":"Crossref","is-referenced-by-count":34,"title":["The Management of Extrapulmonary Poorly Differentiated (High-Grade) Neuroendocrine Carcinomas"],"prefix":"10.1053","volume":"40","author":[{"given":"James","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Reidy-Lagunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2012.11.011_bib1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ygyno.2011.04.011","article-title":"Neuroendocrine tumors of the gynecologic tract: a Society of Gynecologic Oncology (SGO) clinical document","volume":"122","author":"Gardner","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/1097-0142(19910715)68:2<227::AID-CNCR2820680202>3.0.CO;2-I","article-title":"Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin: evidence of major therapeutic activity in the anaplastic variants of these neoplasms","volume":"68","author":"Moertel","year":"1991","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib3","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ecl.2010.08.009","article-title":"Pathology of gastrointestinal disorders","volume":"39","author":"Rindi","year":"2010","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib4","doi-asserted-by":"crossref","first-page":"5609","DOI":"10.1200\/JCO.2007.12.9809","article-title":"Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified?","volume":"25","author":"Ferrone","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib5","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1053\/hupa.2002.129204","article-title":"Classification of low-grade neuroendocrine tumors of midgut and unknown origin","volume":"33","author":"Van Eeden","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib6","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1200\/JCO.2011.35.1817","article-title":"Prognostic validity of a novel American Joint Committee on Cancer Staging Classification for pancreatic neuroendocrine tumors","volume":"29","author":"Strosberg","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib7","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/MPA.0b013e3181ebaffd","article-title":"NANETS consensus guidelines for the diagnosis of neuroendocrine tumor","volume":"39","author":"Vinik","year":"2010","journal-title":"Pancreas"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/PAS.0b013e3182417d36","article-title":"Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors","volume":"36","author":"Yachida","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib9","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/jnci\/djs208","article-title":"TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study","volume":"104","author":"Rindi","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib10","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/MPA.0b013e3181ec124e","article-title":"The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems","volume":"39","author":"Klimstra","year":"2010","journal-title":"Pancreas"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib11","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00428-007-0452-1","article-title":"TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system","volume":"451","author":"Rindi","year":"2007","journal-title":"Virchows Arch"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib12","series-title":"WHO classification of tumours of the digestive system","author":"Bosman","year":"2010"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/cncr.23523","article-title":"Histologic grade is correlated with outcome after resection of hepatic neuroendocrine neoplasms","volume":"113","author":"Cho","year":"2008","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib14","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1245\/s10434-006-9197-3","article-title":"Carcinoid of the rectum risk stratification (CaRRS): a strategy for preoperative outcome assessment","volume":"14","author":"Fahy","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib15","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1200\/JCO.2002.10.030","article-title":"Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups","volume":"20","author":"Hochwald","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib16","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/MPA.0b013e3181ebb56f","article-title":"The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas","volume":"39","author":"Strosberg","year":"2010","journal-title":"Pancreas"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib17","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/PAS.0b013e318159371c","article-title":"Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?","volume":"32","author":"Shia","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib18","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib19","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/sj.bjc.6601758","article-title":"Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases","volume":"90","author":"Brenner","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10350-003-0038-1","article-title":"Neuroendocrine carcinomas of the colon and rectum","volume":"47","author":"Bernick","year":"2004","journal-title":"Dis Colon Rectum"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib21","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.humpath.2009.01.010","article-title":"Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors","volume":"40","author":"Strosberg","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib22","series-title":"AJCC Cancer Staging Manual","year":"2010"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib23","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/00000478-200608000-00003","article-title":"Gastric large cell neuroendocrine carcinomas: a distinct clinicopathologic entity","volume":"30","author":"Jiang","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib24","first-page":"1080","article-title":"Neuroendocrine carcinomas of the colon and rectum: a clinicopathologic evaluation","volume":"104","author":"Staren","year":"1988","journal-title":"Surgery"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib25","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8<1366::AID-CNCR2>3.0.CO;2-D","article-title":"Primary small cell carcinoma of the esophagus: a review of the literature with emphasis on therapy and prognosis","volume":"80","author":"Casas","year":"1997","journal-title":"Cancer"},{"issue":"6 Suppl","key":"10.1053\/j.seminoncol.2012.11.011_bib26","doi-asserted-by":"crossref","first-page":"320S","DOI":"10.1378\/chest.106.6_Supplement.320S","article-title":"A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small cell lung cancer to combination chemotherapy","volume":"106","author":"Lad","year":"1994","journal-title":"Chest"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib27","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1200\/JCO.2002.12.071","article-title":"Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104","volume":"20","author":"Takada","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib28","doi-asserted-by":"crossref","first-page":"e7835","DOI":"10.1371\/journal.pone.0007835","article-title":"Twenty-seven years of phase III trials for patients with extensive disease small-cell lung cancer: disappointing results","volume":"4","author":"Oze","year":"2009","journal-title":"PloS One"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJMoa003034","article-title":"Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer","volume":"346","author":"Noda","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib30","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1200\/JCO.2008.20.1061","article-title":"Phase III trial of irinotecan\/cisplatin compared with etoposide\/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124","volume":"27","author":"Lara","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib31","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM200009283431302","article-title":"Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer","volume":"343","author":"Saltz","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib32","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.ejca.2011.06.002","article-title":"Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer--a randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)","volume":"47","author":"Thuss-Patience","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib33","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/sj.bjc.6690325","article-title":"Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin","volume":"81","author":"Mitry","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/jjco\/hyp173","article-title":"Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the hepatobiliary tract and pancreas","volume":"40","author":"Iwasa","year":"2010","journal-title":"Jpn J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib35","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1200\/JCO.2005.05.0575","article-title":"Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: a Minnie Pearl Cancer Research Network Study","volume":"24","author":"Hainsworth","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib36","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1200\/JCO.1999.17.2.658","article-title":"Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer","volume":"17","author":"von Pawel","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib37","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1200\/JCO.2006.06.5821","article-title":"Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer","volume":"24","author":"O'Brien","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib38","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/0959-8049(94)90455-3","article-title":"Activity of docetaxel (Taxotere) in small cell lung cancer","volume":"30A","author":"Smyth","year":"1994","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib39","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/bjc.1998.54","article-title":"A phase II study of paclitaxel in heavily pretreated patients with small-cell lung cancer","volume":"77","author":"Smit","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib40","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1200\/JCO.2003.09.130","article-title":"Phase II trial of gemcitabine in refractory or relapsed small-cell lung cancer: Eastern Cooperative Oncology Group Trial 1597","volume":"21","author":"Masters","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib41","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000227555","article-title":"Phase II study of vinorelbine in heavily previously treated small cell lung cancer","volume":"53","author":"Furuse","year":"1996","journal-title":"Oncology"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib42","doi-asserted-by":"crossref","first-page":"5448","DOI":"10.1200\/JCO.2006.08.4145","article-title":"Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301","volume":"24","author":"Onoda","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib43","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1097\/CAD.0b013e32827bc61b","article-title":"Marked response to a cisplatin\/docetaxel\/temozolomide combination in a heavily pretreated patient with metastatic large cell neuroendocrine lung carcinoma","volume":"18","author":"Gounaris","year":"2007","journal-title":"Anticancer Drugs"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib44","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12032-010-9789-4","article-title":"Response to temozolomide and bevacizumab in a patient with poorly differentiated neuroendocrine carcinoma","volume":"29","author":"Lindholm","year":"2012","journal-title":"Med Oncol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib45","doi-asserted-by":"crossref","unstructured":"Welin S, Sorbye H, Sebjornsen S, Knappskog S, Busch C, Oberg K. Clinical effect of temozolomide-based chemotherapy in poorly differentiated endocrine carcinoma after progression on first-line chemotherapy. Cancer. Epub 2011 Mar 31.","DOI":"10.1002\/cncr.26124"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib46","first-page":"34","article-title":"Terminology of endocrine tumors of the uterine cervix: results of a workshop sponsored by the College of American Pathologists and the National Cancer Institute","volume":"121","author":"Albores-Saavedra","year":"1997","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib47","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0090-4295(92)90235-O","article-title":"Small cell carcinoma of prostate: effectiveness of hormonal versus chemotherapy","volume":"39","author":"Moore","year":"1992","journal-title":"Urology"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib48","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/01.pas.0000213422.53750.d1","article-title":"Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases","volume":"31","author":"Veras","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib49","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2559.2004.01980.x","article-title":"Small cell carcinoma of the bladder: a contemporary clinicopathological study of 51 cases","volume":"46","author":"Abrahams","year":"2005","journal-title":"Histopathology"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib50","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12022-008-9054-y","article-title":"Primary small cell neuroendocrine carcinoma of the kidney: morphological, immunohistochemical, ultrastructural, and cytogenetic study of a case and review of the literature","volume":"20","author":"La Rosa","year":"2009","journal-title":"Endocr Pathol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib51","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/cncr.20456","article-title":"Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients","volume":"101","author":"Cheng","year":"2004","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib52","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/cncr.20903","article-title":"Small cell carcinoma of the urinary bladder","volume":"103","author":"Choong","year":"2005","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib53","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/IGC.0b013e3181ce427b","article-title":"Unfavorable prognosis of small cell neuroendocrine carcinoma of the uterine cervix: a retrospective matched case-control study","volume":"20","author":"Lee","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ygyno.2003.12.027","article-title":"Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence","volume":"93","author":"Viswanathan","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib55","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/(SICI)1097-0142(19980815)83:4<712::AID-CNCR12>3.0.CO;2-V","article-title":"Prognostic factors in surgically treated small cell cervical carcinoma followed by adjuvant chemotherapy","volume":"83","author":"Chang","year":"1998","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib56","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ygyno.2008.11.010","article-title":"Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy","volume":"112","author":"Zivanovic","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib57","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1309\/3PDN-PMT5-EQTM-H0CD","article-title":"Neuroendocrine carcinomas (carcinoid tumor) of the thymus","volume":"114","author":"Moran","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib58","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/00000478-200009000-00006","article-title":"Small cell carcinoma of the breast: a clinicopathologic and immunohistochemical study of nine patients","volume":"24","author":"Shin","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib59","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/01.pas.0000126776.65815.48","article-title":"Small cell carcinoma of the major salivary glands: clinicopathologic study with emphasis on cytokeratin 20 immunoreactivity and clinical outcome","volume":"28","author":"Nagao","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib60","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ijrobp.2008.08.014","article-title":"Small cell carcinoma of the head and neck: the University of Miami experience","volume":"74","author":"Hatoum","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib61","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.seminoncol.2006.10.024","article-title":"Small cell carcinoma of the head and neck: a review","volume":"34","author":"Renner","year":"2007","journal-title":"Semin Oncol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib62","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s004280100529","article-title":"Alterations of E-cadherin, alpha-catenin and beta-catenin expression in neuroendocrine tumors of the gastrointestinal tract","volume":"440","author":"Li","year":"2002","journal-title":"Virchows Arch"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib63","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1200\/JCO.2007.14.3461","article-title":"Randomized phase II study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103","volume":"26","author":"Rudin","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib64","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/annonc\/mdi365","article-title":"A phase II trial of imatinib (ST1571) in patients with c-kit expressing relapsed small-cell lung cancer: a CALGB and NCCTG study","volume":"16","author":"Dy","year":"2005","journal-title":"Ann Onol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib65","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/JTO.0b013e318155a439","article-title":"A randomized, phase II trial of two dose levels of temsirolimus (CCI-779) in patients with extensive-stage small-cell lung cancer who have responding or stable disease after induction chemotherapy: a trial of the Eastern Cooperative Oncology Group (E1500)","volume":"2","author":"Pandya","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib66","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1200\/JCO.2009.24.7353","article-title":"Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumab","volume":"28","author":"Spigel","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib67","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1097\/JTO.0b013e3181f0bd78","article-title":"Sorafenib in platinum-treated patients with extensive stage small cell lung cancer: a Southwest Oncology Group (SWOG 0435) phase II trial","volume":"5","author":"Gitlitz","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib68","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/JTO.0b013e3181e2fcb0","article-title":"Phase II study of Cediranib (AZD 2171), an inhibitor of the vascular endothelial growth factor receptor, for second-line therapy of small cell lung cancer (National Cancer Institute #7097)","volume":"5","author":"Ramalingam","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib69","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/cncr.23549","article-title":"Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors","volume":"113","author":"Pape","year":"2008","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib70","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1097\/PAS.0b013e31816bf41f","article-title":"Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus","volume":"32","author":"Maru","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib71","first-page":"285","article-title":"Natural history, clinicopathologic classification and prognosis of gastric ECL cell tumors","volume":"71","author":"Solcia","year":"1998","journal-title":"Yale J Biol Med"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib72","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/01.pas.0000157974.05397.4f","article-title":"High-grade neuroendocrine carcinoma of the ampulla of vater: a clinicopathologic and immunohistochemical analysis of 14 cases","volume":"29","author":"Nassar","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib73","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.5858\/2009-0697-OAR.1","article-title":"Carcinoids and high-grade neuroendocrine carcinomas of the ampulla of vater: a comparative analysis of 139 cases from the surveillance, epidemiology, and end results program-a population based study","volume":"134","author":"Albores-Saavedra","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib74","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/MCG.0b013e3181d7a6d4","article-title":"Neuroendocrine tumors of the gallbladder: an evaluation and reassessment of management strategy","volume":"44","author":"Eltawil","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib75","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10120-011-0025-5","article-title":"Neuroendocrine tumors of the stomach: chemotherapy with cisplatin plus irinotecan is effective for gastric poorly-differentiated neuroendocrine carcinoma","volume":"14","author":"Okita","year":"2011","journal-title":"Gastric Cancer"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib76","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0022-5347(17)37390-1","article-title":"Small cell anaplastic carcinoma of the prostate: a clinical, pathological and immunohistological study of 27 patients","volume":"147","author":"Oesterling","year":"1992","journal-title":"J Urol"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib77","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00428-001-0583-8","article-title":"Neuroendocrine carcinomas of the prostate and urinary bladder: a diagnostic and therapeutic challenge","volume":"440","author":"Helpap","year":"2002","journal-title":"Virchows Arch"},{"key":"10.1053\/j.seminoncol.2012.11.011_bib78","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1200\/JCO.2003.01.501","article-title":"Small-cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy","volume":"21","author":"Hoskins","year":"2003","journal-title":"J Clin Oncol"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775412002102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775412002102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T13:35:51Z","timestamp":1644240951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775412002102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0093775412002102"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2012.11.011","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}